Lauren Young
Senior Director - Genomics & Computational Biology Beam Therapeutics
Lauren Young, Senior Director of Genomics & Computational Biology at Beam Therapeutics, has been instrumental in building the company’s genomics capabilities since its early days. She leads multidisciplinary teams spanning experimental and computational off-target analysis, as well as next-generation sequencing. With deep expertise in genome editing and off-target biology, Lauren has supported programs from early research through clinical development and regulatory filings in the U.S. and internationally, playing a key role in advancing base editing technologies toward therapeutic application.
Seminars
Securing regulatory approval for novel genome editing modalities presents unique challenges, with unclear expectations around preclinical pharmacology, toxicity and analytics from agencies. Join this workshop to explore how late-stage and commercial companies are structuring IND packages, bridging preclinical and clinical data, and collaborating directly with regulators. Gain robust strategies to accelerate your program into the clinic.
Workshop highlights:
- Examining how late-stage companies structure IND packages for novel genome editing modalities, helping you build stronger regulatory submissions faster
- Identifying which preclinical outcomes most reliably predict clinical success, enabling you to design more robust studies that satisfy regulatory scrutiny
- Exploring commercial-stage regulatory strategies across new genome editing tools, giving you a roadmap to navigate approval pathways with greater confidence
- Engaging regulators directly in panel discussion to surface industry best practices, empowering you to foster more productive agency relationships for your program
